This study investigated whether Roux-en-Y gastric bypass (RYGB) interacts with obesity-associated hypothalamic inflammation to restore central leptin signaling as a mechanistic account for post-operative appetite suppression. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.